Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for July 2009
July 1, 2009
- Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
- Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals
- CombinatoRx and Neuromed Sign Merger Agreement
- Iressa (Gefitinib) Receives Marketing Authorisation for the Treatment of Non-Small Cell Lung Cancer in Europe
- Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
- Roche Launches Novel Program to Ease Tamiflu Access to Developing Economies
- Pfizer Updates Chantix (varenicline) Labeling in the United States
- Charles River Announces RMS Succession Plan and Organizational Enhancements
July 2, 2009
- Bayer Files Patent Infringement Lawsuit Against Teva
- Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
- Current Status of the Development Programs of New Indications and Formulations for Aricept for Enhancing Patient Value
- GSK Further Extends its Product Portfolio in the Middle East and North Africa
- Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
July 6, 2009
- Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of Subsequent Offering Period
- Novo Nordisk's Victoza (liraglutide) Receives Marketing Authorisation in Europe (3 July 2009)
- Grassley Asks Top Medical Journals About Ghostwriting
July 7, 2009
- SDI Reports: Sanofi-aventis U.S. Joins Ranks of Merck and GlaxoSmithKline as Three Companies Most Respected by Pediatricians, According to SDI Pharmaceutical Company Image Study
- European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
- Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
- Thallion Suspends Patient Enrollment of TLN-232 Metastatic Melanoma Trial Over Licensing Dispute
- Teva Provides Update on Generic Ortho Tri-Cyclen Lo
- NexMed Announces Decision for Anti-Fungal Product
July 8, 2009
- Biogen Idec Receives Fast Track Designation from FDA for PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
- Verilogue Study of More Than 20,000 Real-Life Patient-Physician Interactions Reveals Patients' Top Health-Related Fears
- Sermo Survey of US Physicians Indicates AMA No Longer Represents Them
- 12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource
- Japanese Ministry of Health approves Rasilez, a first-in-class direct renin inhibitor (DRI), for the treatment of high blood pressure
July 9, 2009
- ICON Acquires Veeda Laboratories Limited
- EU: Antitrust: Shortcomings in Pharmaceutical Sector Require Further Action
- New Senate Biosimilars Proposal Would Jeopardize New Medical Advancements and Cures
- NICE Upholds GSK Appeal for Advanced Breast Cancer Treatment, Tyverb (lapatinib)
- WHO Grants Prequalification to Cervarix
- MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
- Pfizer To Appeal Canadian Federal Court Decision On Company's Norvasc Patent
- ratiopharm Canada wins important patent legal battle with Pfizer
July 10, 2009
- Asmanex (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
- Remeron Now Approved in Japan for the Treatment of Depression in Adult Patients
- Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to Lexapro Patent Litigation
- Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro (escitalopram oxalate) ANDA Patent Litigation
- Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
- Alimta (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
July 13, 2009
July 14, 2009
- Oscient Pharmaceuticals Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
- HHS Purchases Additional H1N1 Vaccine Ingredients
- Indy Lights Racer Charlie Kimball Will Not Let Diabetes Slow Him Down
- Wyeth's Prevenar 13* Receives First Approval
July 15, 2009
- FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
- Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
- Hormone Therapy Use Associated With Increased Risk of Ovarian Cancer
- Expert Statement Issued about Lantus Following Recent Publications in Diabetologia
- FDA Sends Warning Letter to Apotex
- Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN(ezetimibe/simvastatin) and ZETIA (ezetimibe)
July 16, 2009
- Baxter Reports Strong Second Quarter 2009 Financial Results and Raises Full-Year Outlook
- Phillip A. Sharp to Retire from Biogen Idec Board
- Biogen Idec Reports Second Quarter 2009 Results
- Novartis Delivers Strong Operational Performance In The First Half Of 2009 Driven By Sustained Pharmaceuticals Innovation
- PharmaTelevision Launches New Premium Content Service
July 17, 2009
- Biopure Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
- FDA Reviewing Preliminary Safety Information on Asthma Drug Xolair
- Luna Innovations Files for Chapter 11 Reorganization
- Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada With Gilead Sciences
- Pro-Pharmaceuticals Prevails in Trade Secret Lawsuit
July 20, 2009
July 21, 2009
- Merck Announces Second-Quarter 2009 Financial Results
- Schering-Plough Reports Financial Results for 2009 Second Quarter
- Elan Reports Second Quarter 2009 Financial Results
- FDA Approves Vaccine for 2009-2010 Seasonal Influenza
- Forest Laboratories, Inc. Reports Fiscal First Quarter 2010 Earnings Per Share of $0.87
- EPIX Pharmaceuticals Assigns All of Its Assets for the Benefit of Creditors
- Ontario, Canada Leading World-Class Research on New Cancer Drugs
July 22, 2009
- DellaCamera Advised That Enzon Has Set July 24, 2009 as Record Date for Consent Solicitation
- Pfizer Reports Second-Quarter 2009 Results; Increases Full-Year 2009 Adjusted Diluted EPS(1) Guidance
- Gilead Sciences Announces Record Second Quarter 2009 Financial Results
- Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
- SEC Charges Perry Corp. With Disclosure Violations in Vote Buying Scheme
- Vaxine Wins Line Honours With World's First Human Swine Flu Vaccine
July 23, 2009
- Bristol-Myers Squibb to Acquire Medarex
- Alcon and AstraZeneca to Collaborate on Eye Drug Development
- Large Pharmaceutical Firms Are Getting More Drugs Into Development While Terminating Unpromising Candidates
- Excellent Performance Highlights Second Quarter for Bristol-Myers Squibb
- Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
- Double-digit increase in sales, operating profit1 and Core EPS
- JMI Launches Specialty, Professional and Social Networking Site for Pharmacy Industry
July 24, 2009
- Q2/2009: Merck Revenues Remain Steady at ? 1.9 Billion
- Teva and Ortho-McNeil-Janssen Settle Ortho Tri-Cyclen Lo Litigation
- Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
- Ambrilia Biopharma Inc.: Termination of Study 303 and Update On C2L Development
July 27, 2009
- Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
- Sanofi Pasteur Strengthens Vaccines Position in India Through the Control of Shantha Biotechnics via Mérieux Alliance
July 28, 2009
- Good First Six Months In 2009 For Boehringer Ingelheim - Successful Products Spiriva®, Micardis And Flomax Secure Good Growth
- Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
- Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.
- Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
- Mylan Reports That the FDA Determined That All Accusations Were Unfounded
- NHLBI Stops Study Of Treatment For Pulmonary Hypertension In Patients With Sickle Cell Disease Due To Safety Concerns
- Insmed Provides Update on Supply of Iplex
July 29, 2009
- Sanofi-aventis Announces Second Quarter 2009 Results
- Pfizer Announces Partnership With Shanghai Institutes For Biological Sciences For Drug Discovery Activities
- Bayer robust in a difficult environment
July 30, 2009
- Sanofi-aventis to Acquire Merck's Interest in Merial
- H. Lundbeck A/S (DK) - Pipeline update - following an interim analysis the studies with bifeprunox for the treatment of schizophrenia is discontinued
- Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
- AstraZeneca PLC: Second Quarter And Half Year Results 2009
- Pfizer, Kano State Reach Settlement Of Trovan Cases
July 31, 2009
- Accreditation Council for Continuing Medical Education Chief Executive Testifies at Senate Hearing
- Genzyme Corporation (GENZ) Target of Investigation for Potential Securities Law Violations, Hagens Berman Announces
- Lilly Announces Continued Commitment to Transparency with Faculty Registry
- Genzyme Provides Update on Allston Landing Plant
- Ligand and Organon Mutually Terminate Collaboration and License Agreement
- Averion Announces Organizational Realignment
